Search results for: 'research area apoptosis mdm2'
-
A4234 TW-371 CitationTarget: Bcl-2|Bcl-xl|Mcl-1Summary: Bcl-2 inhibitor, inhibits Bcl-2,Bcl-XL and Mcl-1
-
A4484 PRIMA-1METSummary: Restore mutant p53 activity, induce BAX and PUMA
-
A8634 WEHI-539 hydrochloride1 CitationSummary: Bcl-xL inhibitor,high affinity and selective
-
A3343 D609Target: PC-PLCSummary: PC-PLC inhibitor
-
A3707 Pemetrexed disodium hemipenta hydrateSummary: Antifolate and antimetabolite agent
-
A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
-
A3847 SU5416Target: VEGFRSummary: VEGF receptor inhibitor and AHR agonist
-
A2604 CelastrolTarget: ProteasomeSummary: Antioxidant, anti-inflammatory and immunosuppressive agent
-
A4211 Lenalidomide (CC-5013)Target: angiogenesisSummary: Antineoplastic agent,inhibits angiogenesis
-
A4212 Pomalidomide (CC-4047)Summary: Immunomodulator,antumor/anti-angiogenic